How do you make $210M in 3 years?

Easy, if you're Invitrogen: start with $500M and buy a drug discovery services company (BioReliance).

Guh!

Based on public info, IVGN bought BREL for about 6X sales, and sold them 3 years later for 1.9X sales.

This news makes it onto this blog 'cuz:

1) IVGN, thru the former Panvera is the second best provider of kinase specificity testing,
2) the GM of BioReliance is an Upstate alum. (Good luck, Ted.)
3) This allows me to yet again tweak my friends at IVGN, Sue and Chris. Sue, still using that snorkel I sent you to find your IVGN stock options?